OMC
Overbrook Management Corp’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,837
| Closed | -$232K | – | 53 |
|
|
2024
Q3 | $232K | Hold |
6,837
| – | – | 0.05% | 51 |
|
|
2024
Q2 | $253K | Sell |
6,837
-252
| -4% | -$9.33K | 0.06% | 50 |
|
|
2024
Q1 | $298K | Sell |
7,089
-555
| -7% | -$23.3K | 0.08% | 51 |
|
|
2023
Q4 | $303K | Hold |
7,644
| – | – | 0.06% | 55 |
|
|
2023
Q3 | $210K | Sell |
7,644
-119
| -2% | -$3.28K | 0.05% | 58 |
|
|
2023
Q2 | $263K | Hold |
7,763
| – | – | 0.06% | 59 |
|
|
2023
Q1 | $279K | Sell |
7,763
-312
| -4% | -$11.2K | 0.07% | 63 |
|
|
2022
Q4 | $360K | Hold |
8,075
| – | – | 0.1% | 56 |
|
|
2022
Q3 | $227K | Sell |
8,075
-165
| -2% | -$4.64K | 0.06% | 69 |
|
|
2022
Q2 | $222K | Hold |
8,240
| – | – | 0.06% | 78 |
|
|
2022
Q1 | $281K | Buy |
+8,240
| New | +$281K | 0.06% | 77 |
|
|
2019
Q1 | – | Sell |
-48,611
| Closed | -$10K | – | 71 |
|
|
2018
Q4 | $10K | Hold |
48,611
| – | – | ﹤0.01% | 71 |
|
|
2018
Q3 | $22K | Hold |
48,611
| – | – | ﹤0.01% | 74 |
|
|
2018
Q2 | $24K | Hold |
48,611
| – | – | ﹤0.01% | 72 |
|
|
2018
Q1 | $113K | Hold |
48,611
| – | – | 0.02% | 75 |
|
|
2017
Q4 | $138K | Hold |
48,611
| – | – | 0.03% | 76 |
|
|
2017
Q3 | $139K | Sell |
48,611
-7,500
| -13% | -$21.4K | 0.03% | 70 |
|
|
2017
Q2 | $139K | Buy |
+56,111
| New | +$139K | 0.03% | 77 |
|